SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000914475-23-000073
Filing Date
2023-10-31
Accepted
2023-10-31 07:02:45
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nbix-20230930.htm   iXBRL 10-Q 1172621
2 EX-31.1 q3-2023xexhibit311.htm EX-31.1 10199
3 EX-31.2 q3-2023xexhibit312.htm EX-31.2 10214
4 EX-32 q3-2023xexhibit32.htm EX-32 9790
10 GRAPHIC nbix-20230930_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-23-000073.txt   6097651

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20230930.xsd EX-101.SCH 41106
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nbix-20230930_cal.xml EX-101.CAL 80611
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nbix-20230930_def.xml EX-101.DEF 154874
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20230930_lab.xml EX-101.LAB 585855
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20230930_pre.xml EX-101.PRE 342529
59 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20230930_htm.xml XML 806859
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22705 | Film No.: 231362245
SIC: 2836 Biological Products, (No Diagnostic Substances)